New drug combo tested to fight tough head and neck cancers
Disease control
Completed
This study tested if adding an experimental drug called setanaxib to an existing immunotherapy (pembrolizumab) could help shrink tumors more effectively in patients with advanced head and neck cancer that had returned or spread. It involved 55 patients who were randomly assigned …
Phase: PHASE2 • Sponsor: Calliditas Therapeutics Suisse SA • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC